The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer’s disease-Reference-Cited by-同舟云学术

The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer’s disease

Published:2022-07 Issue:7 Volume:30 Page:2474-2490
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Musardo Stefano^ORCID,Therin Sebastien,Pelucchi Silvia,D’Andrea Laura,Stringhi Ramona,Ribeiro Ana^ORCID,Manca Annalisa,Balducci Claudia,Pagano Jessica,Sala Carlo^ORCID,Verpelli Chiara^ORCID,Grieco Valeria^ORCID,Edefonti Valeria^ORCID,Forloni Gianluigi^ORCID,Gardoni Fabrizio,Meli Giovanni,Di Marino Daniele,Di Luca Monica,Marcello Elena^ORCID

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference59 articles.

1. Alzheimer’s disease is a synaptic failure;Selkoe;Science,2002

2. The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease;Colom-Cadena;Alzheimers Res. Ther.,2020

3. Alzheimer’s disease: the amyloid cascade hypothesis;Hardy;Science,1992

4. Alpha, beta-and gamma-secretases in Alzheimer’s disease;Epis;Front. Biosci. (Schol. Ed.),2012

5. ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons;Kuhn;EMBO J.,2010

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ADAM10 isoforms: Optimizing usage of antibodies based on protein regulation, structural features, biological activity and clinical relevance to Alzheimer’s disease;Ageing Research Reviews;2024-11

2. Propane-2-sulfonic acid octadec-9-enyl-amide, a novel PPARα/γ dual agonist, attenuates molecular pathological alterations in learning memory in AD mice;Neurological Research;2024-04-05

3. AAV mediated carboxyl terminus of Hsp70 interacting protein overexpression mitigates the cognitive and pathological phenotypes of APP/PS1 mice;Neural Regeneration Research;2024-03-01

4. Plasma ADAM10 Levels and Their Association with Alzheimer’s Disease Diagnosis in Older Adults with Fewer Years of Formal Education;Dementia and Geriatric Cognitive Disorders;2024

5. A disintegrin and metalloproteinases (ADAMs) and tumor necrosis factor-alpha-converting enzyme (TACE);Metalloenzymes;2024